We report a case of acute aortic dissection (Stanford type B) that occurred in pregnant woman at 34-week gestation. She had no systemic characteristics of Marfan syndrome, however she exhibited a mutation of FBN1, Arg 545 Cys, which has been found to correlate with ectopia lentis but not with aortic dissection.
INTRODUCTION
Pregnancy is strongly associated with life-threatening problems in Marfan patients. Herein, we report a case of aortic dissection during pregnancy with a rare combination of the clinical manifestation and FBN1 mutation.
CASE
A 31-year-old woman, 2 gravida 1 para, was referred to our hospital at 34-week gestation because of acute aortic dissection type B. She had no family history of aortic dissection, or sudden death. She was 167 cm tall and weighed 80 kg before pregnancy. She had experienced sudden severe pain in her chest and was transferred to a tertiary care center. She was conscious and alert. She did not show either thumb sign, wrist sign or hind foot deformity in physical examination. Her arm span/ height ratio was 1.02 (o1.05). Her blood pressure (BP) was 110B140 mm Hg, heart rate 80 b.p.m., oxygen saturation SpO 2 99B100%, cardiac ultrasonography revealed good left ventricular ejection fraction of 74%, left ventricle end-diastolic dimension/ end-systolic dimension of 53/33 mm. She did not exhibit mitral valve prolapse or aortic valve regurgitation, or dilatation of ascending aorta. Tricuspid valve regurgitation was minimal, the diameter of the inferior vena cava was 16 mm, and there were no indications of pulmonary arterial hypertension. Electrocardiography showed no specific ST changes. Contrast computerized tomography showed aortic dissection from just after the branch of the left subclavian artery to the level of the atrium, but did not show dura ectasia. To control the BP, Nicardipine 3 ml per hour (0.5 g) was started and the BP was maintained at around 110B120/ mm Hg.
Fentanyl (0.5 mg per day) was administered as an analgesia. Three hours later, she felt another chest pain and the dissected area progressed to the level of the renal artery and she was transferred to our hospital. She was conscious and alert, with BP 124/60, heart rate 110 b.p.m. There was no sign of rales and the respiratory rate was 20 per minute. She had no clinical features suggestive of Marfan syndrome. The fetus was in position for cephalic presentation and the estimated fetal body weight was 2200 g. Cardiotocography reassured that the fetus was in no difficulty. As celiac, supra mesenteric and renal arterial blood flow was adequate with no elevation of lactate level, there was no indication for the operation for the aortic dissection.
As the baby was mature enough for extra-uterine life and the mother required further intensive care, including BP control, pain control and follow-up CT scan examination, we decided to perform cesarean section. Cesarean section was performed under general anesthesia, and a 2350 g healthy baby was delivered. During the postpartum course, for BP control, Nicardipine was continued with 0.5 g and dose was increased to 2.5 g when she was extubated the next day and was maintained until 7 days postpartum. For the pain control Loxoprophen 120 mg per day was started on the day 1 postpartum, and maintained for 7 days.
The patient increased her activities incrementally each day after the surgery. Schellong test and 50-m walking test was performed on the day 3 and 7 postpartum, respectively, and there were no changes in her BP or heart rate. The patient was discharged from the hospital on the day 10 postpartum with no changes in the dissected areas. The genetic study was performed by direct sequencing of genomic DNA from peripheral blood leukocytes and complementary DNA from fibroblast RNA derived from intraoperative skin biopsy. Study results revealed a heterozygous missense mutation of c.1633C to T (p.Arg545Cys) in FBN1 gene.
DISCUSSION
This patient had a missense mutation of FBN1 (p.Arg545Cys), which has been specifically observed in six patients with lens subluxation in previous reports. [1] [2] [3] [4] The patient developed descending aortic dissection, but had no enlargement of the ascending aorta, which might not be typical of aortic lesions in Marfan syndrome, though Marfan patients with aortic dissection in the descending aorta were reported. 5, 6 Furthermore, no physical findings specific to Marfan syndrome were observed in this patient. Although aortic dissection is a rare complication that can develop during pregnancy, 7, 8, 12 pregnancy is strongly associated with lifethreatening problems particularly in Marfan patients. 8, 9 Aortic dissection events in pregnancy were reviewed in the aspect of its prevalence, etiology and subtypes of type A and type B, previously. 10, 11 The risk of aortic dilatation or dissection increases during and after pregnancy in patients with Marfan syndrome due to superimposition of the hyperdynamic and hypervolemic circulatory state of pregnancy on the preexisting weakness of the aortic media. 9 Marfan syndrome is an autosomal dominant connective tissue disorder, and is associated with a higher risk of aortic dissection. [13] [14] [15] The above-mentioned results suggests that we should explain the genetics of the disease and provide genetic diagnosis, such as FBN1, for aortic dissection patients during pregnancy in order to identify the possible risk of aortic dissection, even if they are not considered as having Marfan syndrome.
